You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

Corneal Collagen Cross Linking

By Dermot - 17th Nov 2017 | 14 views

Corneal collagen cross linking (CXL) is a relatively recent advance in ophthalmology, which has been shown to strengthen the biomechanical properties of the pathologically thinning (ectasia) of the cornea. Since its first reported use some 15 years ago, it has revolutionised treatment of keratoconus, pellucid marginal degeneration and post-refractive surgery ectasia by offering a treatment for corneal ectatic conditions, which previously may have required corneal transplant. This timely book, c0-edited by renowned Irish ophthalmologist Mr Arthur Cummings, describes the state of play of CXL treatment and acts as a reference text for the current and evolving practice of CXL.

There are over 50 international contributors to this edition who give their invaluable personal experience of CXL while also discussing the current evidence-based practice. The book is laid out in nine chapters and while sometimes dense with text, summary boxes at the end of large sections can be easily referenced to recap on pertinent points.

In the early chapters of this book, the nature of corneal ectatic diseases, in particular keratoconus, is detailed along with evolving methods for diagnosis. Clinical signs present in established and late disease, previously relied on for diagnosis, are clearly illustrated with patient images. Recent advances in technology developed for refractive surgery are described, which integrate multiple parameters to diagnose and grade severity of corneal disease before the onset of overt clinical signs. Examples of data output from these corneal scans are illustrated with useful and descriptive examples, which allow the reader to confidently diagnose corneal ectasias in their clinical practice.

The principles of CXL are reviewed while discussing the evolution of optimising treatment. The various treatment modalities and the evidence-base for each is discussed, while also importantly including the limitations of each technique. The rationale and outcomes of newer accelerated treatment options are reported in an unbiased way as well as combination of CXL with refractive surgery procedures.

Clinical cases with corneal photographs paired with imaging data effectively discusses the more challenging and controversial opinions in CXL such as paediatric cases, retreatment and early intervention prior to visual symptoms.

A comprehensive review of clinical CXL results as well as basic science models of the disease is included in an unbiased manner. The authors frequently refer to practical outcomes for patients from their own experiences also. The intra-operative, post-operative and long-term follow-up of patients is described, as well as giving a detailed look at clinical parameters affecting outcome. As most complications of CXL are related to epithelial problems post-procedure, the evidence for newer epithelium-on versus epithelium-off techniques is discussed. Newer techniques entering the clinical arena such as inophoresis is also included in detail.

An entire chapter is dedicated to CXL in children as the benefit in preventing progression requiring corneal grafting is greatest in children. Response may not be as predictable as it is for adults, with results from some paediatric trials showing potential for improvement superior to the stabilisation effect seen in adults. This chapter also gives practical steps for CXL in children, which is extremely useful given that CXL in the paediatric age group is currently not done frequently. Specific challenges in this age group are discussed including parameters for progression of keratoconus.

The final chapter discusses the future of CXL. This chapter sets out what is required to further optimise the CXL procedure. Newer advances such as accelerated techniques to make the procedure shorter and leaving the epithelium intact for patient comfort are included. The remainder of this chapter discusses the additive role of CXL being investigated in treatment of corneal infections, corneal oedema and concurrent with refractive procedures.

The uptake in CXL procedures has increased exponentially in the last number of years, despite the fact that evidence for long-term corneal stability post-procedure is relatively lacking. This point is openly referenced throughout the book with many of the studies cited being retrospective studies rather than prospective. However, that being said, this book summarises the available literature well – sometimes in tabulated formula describing study size and duration so the reader can make up their own mind as to the value of each study.

Writing a book on CXL is difficult in an era when this new treatment is rapidly evolving. This book is beneficial as a reference manual for any ophthalmology unit, which undertakes CXL-ing procedures. It would also be beneficial to opticians, ophthalmic nurses and technicians interested in CXL and treatment of corneal diseases. This book accurately describes the CXL procedure in its completeness as our knowledge stands, while including putative roles currently under investigation and in early clinical practice for the future.

Leave a Reply

[the_ad_placement id="main-mpu-public"]
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]